Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024

Description

Australia & New Zealand Research Antibodies Market Growth & Trends:

The Australia & New Zealand research antibodies market size is expected to reach USD 77.6 million by 2030, registering a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Drivers of this market include rise in R&D initiatives being undertaken by biopharmaceutical & biotechnology companies, increase in government investments on R&D, and growth in neurobiology & stem cell research.

Rise in R&D investments and research activities by various pharmaceutical and biotechnology companies to develop new & innovative products is anticipated to fuel market growth. For instance, in March 2019, the Federal Government invested USD 150 million in Stem Cells Australia and University of Melbourne to support R&D pertaining to stem cell and explore new ways to treat various life-threatening conditions such as stroke, congenital heart disease, and kidney disease.

Growth in stem cell and neurobiology-based research is expected to boost the market during the forecast period. There are a number of neurobiology-based research institutes in Australia. For instance, the Center of Research Excellence in Neuromuscular Disorders, Australia, is a collaboration between neuromuscular experts.

Ongoing launch of new products is anticipated to fuel market growth over the forecast period. For instance, in April 2019, Bio-Rad launched a range of isotype-specific secondary antibodies-IgG1, IgG2a, and IgG2b. These products are used for specificity in ELISA, imaging, western blotting, and flow cytometry as well as to improve signaling.

Increasing adoption of strategies, such as collaborations and acquisitions, by leading market players is expected to fuel market growth. For instance, in March 2016, Thermo Fisher Scientific Inc., announced the acquisition of Affymetrix, Inc. This strategic acquisition was aimed at strengthening the company's position in the field of bioscience and expanding its portfolio of antibodies.

New Zealand has been investing heavily in R&D in order to promote trade in biotechnology sector. According to Research, Science and Innovation System Performance Report, the nation's total expenditure on R&D was estimated to be 1.23% of GDP in 2016. This was funded by both public and private firms in New Zealand. Data from the same source also indicates that the country's science system is highly productive in terms of publications per researcher, with over USD 653,400 spent on research and higher education.

Australia & New Zealand Research Antibodies Market Report Highlights:

Primary antibodies held dominant share of the product segment in 2023. This can be attributed to wide applications of these antibodies in research
Monoclonal antibodies held significant share of the type segment in 2023, mainly due to their efficient staining properties and high specificity for detection of antigens
Western blotting held the largest share of the technology segment owing to rising demand for rapid diagnostic methods
On the basis of technology, ELISA is anticipated to witness the highest CAGR during the forecast period, owing to conventional use of polyclonal antibodies for sandwich ELISA
On the basis of source, mouse segment held the largest share of the Australia & New Zealand research antibodies market in 2023, as mice are convenient to use during production of antibodies for research purposes

Product Code: GVR-3-68038-656-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Australia & New Zealand Research Antibodies Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Australia & New Zealand Research Antibodies Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Australia & New Zealand Research Antibodies Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Australia & New Zealand Research Antibodies Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Primary
- 4.3.1. Primary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Secondary
- 4.4.1. Secondary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Australia & New Zealand Research Antibodies Market: Specificity Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Australia & New Zealand Research Antibodies Market: Specificity Movement Analysis, USD Million, 2023 & 2030
5.3. Monoclonal Antibodies
- 5.3.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Polyclonal Antibodies
- 5.4.1. Polyclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Australia & New Zealand Research Antibodies Market: Technology Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Australia & New Zealand Research Antibodies Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Immunohistochemistry
- 6.3.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Immunofluorescence
- 6.4.1. Immunofluorescence Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Western blotting
- 6.5.1. Western blotting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Flow cytometry
- 6.6.1. Flow cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Immunoprecipitation
- 6.7.1. Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. ELISA
- 6.8.1. ELISA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Others
- 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Australia & New Zealand Research Antibodies Market: Source Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Australia & New Zealand Research Antibodies Market: Source Movement Analysis, USD Million, 2023 & 2030
7.3. Mice
- 7.3.1. Mice Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Rabbit
- 7.4.1. Rabbit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Goat
- 7.5.1. Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Others
- 7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Australia & New Zealand Research Antibodies Market: Application Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Australia & New Zealand Research Antibodies Market: Application Movement Analysis, USD Million, 2023 & 2030
8.3. Infectious Diseases
- 8.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Immunology
- 8.4.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Oncology
- 8.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Stem Cells
- 8.6.1. Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Neurobiology
- 8.7.1. Neurobiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Others
- 8.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Australia & New Zealand Research Antibodies Market: End-use Estimates & Trend Analysis

9.1. Segment Dashboard
9.2. Australia & New Zealand Research Antibodies Market: End-use Movement Analysis, USD Million, 2023 & 2030
9.3. Hospitals
- 9.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Non-Hospitals
- 9.4.1. Non-Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Australia & New Zealand Research Antibodies Market: Country Estimates & Trend Analysis

10.1. Australia & New Zealand Research Antibodies Market Share, By Country, 2023 & 2030, USD Million
10.2. Australia
- 10.2.1. Australia Research Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.3. New Zealand
- 10.3.1. New Zealand Research Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

11.1. Recent Developments & Impact Analysis by Key Market Participants
11.2. Company Categorization
11.3. Company Heat Map Analysis
11.4. Company Profiles
- 11.4.1. Abcam Limited
  - 11.4.1.1. Participant's Overview
  - 11.4.1.2. Financial Performance
  - 11.4.1.3. Product Benchmarking
  - 11.4.1.4. Recent Developments/ Strategic Initiatives
- 11.4.2. Bio-Rad Laboratories, Inc.
  - 11.4.2.1. Participant's Overview
  - 11.4.2.2. Financial Performance
  - 11.4.2.3. Product Benchmarking
  - 11.4.2.4. Recent Developments/ Strategic Initiatives
- 11.4.3. BD
  - 11.4.3.1. Participant's Overview
  - 11.4.3.2. Financial Performance
  - 11.4.3.3. Product Benchmarking
  - 11.4.3.4. Recent Developments/ Strategic Initiatives
- 11.4.4. Merck KGaA
  - 11.4.4.1. Participant's Overview
  - 11.4.4.2. Financial Performance
  - 11.4.4.3. Product Benchmarking
  - 11.4.4.4. Recent Developments/ Strategic Initiatives
- 11.4.5. Lonza
  - 11.4.5.1. Participant's Overview
  - 11.4.5.2. Financial Performance
  - 11.4.5.3. Product Benchmarking
  - 11.4.5.4. Recent Developments/ Strategic Initiatives
- 11.4.6. Thermo Fisher Scientific Inc.
  - 11.4.6.1. Participant's Overview
  - 11.4.6.2. Financial Performance
  - 11.4.6.3. Product Benchmarking
  - 11.4.6.4. Recent Developments/ Strategic Initiatives
- 11.4.7. Cell Signaling Technology, Inc.
  - 11.4.7.1. Participant's Overview
  - 11.4.7.2. Financial Performance
  - 11.4.7.3. Product Benchmarking
  - 11.4.7.4. Recent Developments/ Strategic Initiatives
- 11.4.8. F. Hoffmann-La Roche Ltd.
  - 11.4.8.1. Participant's Overview
  - 11.4.8.2. Financial Performance
  - 11.4.8.3. Product Benchmarking
  - 11.4.8.4. Recent Developments/ Strategic Initiatives
- 11.4.9. Agilent Technologies, Inc.
  - 11.4.9.1. Participant's Overview
  - 11.4.9.2. Financial Performance
  - 11.4.9.3. Product Benchmarking
  - 11.4.9.4. Recent Developments/ Strategic Initiatives
- 11.4.10. Revvity
  - 11.4.10.1. Participant's Overview
  - 11.4.10.2. Financial Performance
  - 11.4.10.3. Product Benchmarking
  - 11.4.10.4. Recent Developments/ Strategic Initiatives

Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024 - 2030